
Pramodini Medicare Ltd IPO
Last updated:
Pramodini Medicare Ltd IPO Price Range is ₹110 - ₹118, with a minimum investment of ₹2,83,200 for 2400 shares per lot.
Subscription Rate
3.659x
as on 14 Aug 2026, 07:00PM IST
Minimum Investment
₹2,83,200
/ 2400 shares
IPO Status
Price Band
₹110 - ₹118
Bidding Dates
Aug 12, 2026 - Aug 14, 2026
Issue Size
₹69.04 Cr
Lot Size
1200 shares
Min Investment
₹2,83,200
Listing Exchange
NSE
Pramodini Medicare Ltd IPO Application Timeline




IPO Subscription Status
as on 14 Aug 2026, 07:00PM IST
IPO subscribed over
🚀 3.659x
This IPO has been subscribed by 3.486x in the retail category and 3.657x in the QIB category.
Subscription Rate
| Total Subscription | 3.659x |
| Retail Individual Investors | 3.486x |
| Qualified Institutional Buyers | 3.657x |
| Non Institutional Investors | 3.931x |
Strengths and Risks
Strengths
Establishing a Strategic presence across various states of India.
Strengthening Our Network with Diversified Models.
Technical Capability with robust IT Infrastructure.
Dedicated Management Team with Significant Industry Experience.
Track record of revenue and financial performance.
Diverse Customer cum Patient Base.
Risks
A significant portion of the companys revenue from operations is derived from MOUs with government authorities under PublicPrivate Partnership (PPP) arrangements. Any non-renewal, modification, or termination of such MOUs, or delays orfailures in realizing payments from government authorities, may materially and adversely affect its business, financialcondition and results of operations.
Concentrated emphasis on radiology services also exposes it to substantial risks that could adversely impact the companys operations, financial performance, and long-term growth prospects.
The company derives substantial portion of its revenue from the state of Andhra Pradesh and any loss of business in such regionscould have an adverse effect on the companys business, results of operations and financial condition.
The company is majorly dependent on certain key customers cum patients for a substantial portion of its revenues. Loss ofrelationship with any of these customers cum patients may have a material adverse effect on the companys profitability and resultsof operations.
The company derives a significant portion of its revenue from government authorities (B2G). Any reduction in revenue from themor delays in payments by government authorities, may adversely affect the companys business, financial condition and results ofoperations.
Failures to establish and comply with appropriate quality standards when performing diagnostics services could resultin litigation and liability for it and could materially and adversely affect its reputation and results of operations.
The company relies on its information technology systems in providing the companys diagnostic services and managing its operations, andany disruption to such systems or networks could adversely affect the companys business operations, reputation and financialperformance.
Any inadequacy in packaging, collection of, or failures or delay in the delivery of, specimens to the companys diagnostic centrescould compromise or destroy the integrity of such specimens, which could adversely affect the companys business, results ofoperations and financial condition.
The Company is not having any exact comparable Indian peer which have similar business to the Company.
The company is required to furnish bank guarantees as part of its business under Strategic Partnership with PSU Govt of India.The companys inability to arrange such guarantees or the invocation of such guarantees may adversely affect its cash flows andfinancial condition.
How to Apply for Pramodini Medicare Ltd IPO on INDmoney
- Download the INDmoney app and complete your KYC.
- Go to INDstocks → IPO, or just search “IPO”.
- Tap on Pramodini Medicare Ltd IPO from the list of live IPOs.
- View key details like price band, lot size, and dates.
- Tap Apply Now and choose your number of lots.
- Use INDpay UPI for instant mandate tracking.
- Your funds will be blocked until the share allotment is finalized.